InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Bumpus Namandje. Officer active across 1 company, notably Recursion Pharmaceuticals, INC.. In total, 1 filings have been logged. History available since 17 March 2025. The latest transaction was disclosed on 17 March 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration